InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Paul Mahon. Director active across 1 company, notably UNITED THERAPEUTICS CORPORATION. Aggregated, 6 filings have been recorded. Activity tracked since 4 June 2026. The latest transaction was disclosed on 3 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
PAUL MAHON is a declarant linked to UNITED THERAPEUTICS CORPORATION, where he is an Officer. He has 5 filings in total, and in the recent filings observed they are all sales, totaling EUR 19276374 between 2026-06-04 and 2026-08-20; the most common transaction nature is Notice of proposed sale (Form 144).